260 related articles for article (PubMed ID: 5009064)
21. Direct inhibition of pituitary LH secretion in rats by CB-154 (2-Br-alpha-ergocryptine).
Seki M; Seki K; Yoshihara T; Watanabe N; Okumura T
Endocrinology; 1974 Mar; 94(3):911-4. PubMed ID: 4591828
[No Abstract] [Full Text] [Related]
22. Porcine blood and hypophyseal prolactin values.
Threlfall WR; Dale HE; Martin CE
Am J Vet Res; 1974 Dec; 35(12):1491-3. PubMed ID: 4433065
[No Abstract] [Full Text] [Related]
23. Hypothalamic control of prolactin secretion.
Meites J; Clemens JA
Vitam Horm; 1972; 30():165-221. PubMed ID: 4565620
[No Abstract] [Full Text] [Related]
24. DNA synthesis and the secretion of prolactin and growth hormone by the pituitary gland of the male rat: effects of diethylstilboestrol and 2-bromo-alpha-ergocryptine methanesluphonate.
Davies C; Jacobi J; Lloyd HM; Meares JD
J Endocrinol; 1974 Jun; 61(3):411-7. PubMed ID: 4366118
[No Abstract] [Full Text] [Related]
25. Ultrastructural observation of pituitary release of prolactin in the rat by suckling stimulus.
Shiino M; Williams G; Rennels EG
Endocrinology; 1972 Jan; 90(1):176-87. PubMed ID: 5009057
[No Abstract] [Full Text] [Related]
26. Effects of 2-Br- -ergocryptine on plasma prolactin level and milk yield in cows.
Karg H; Schams D; Reinhardt V
Experientia; 1972 May; 28(5):574-6. PubMed ID: 4557302
[No Abstract] [Full Text] [Related]
27. Inhibition by 2-Br alpha-ergocryptine-mesilate (CB-154) of suckling-induced pituitary prolactin depletion in lactating rats.
Flückiger E; Kovacs E
Experientia; 1974 Oct; 30(10):1173. PubMed ID: 4435126
[No Abstract] [Full Text] [Related]
28. Prolactin, its control and clinical significance.
Friesen HG
Clin Sci; 1973 Feb; 44(2):2P-3P passim. PubMed ID: 4723275
[No Abstract] [Full Text] [Related]
29. Effects of 2-Br- -ergokryptine on plasma prolactin level during parturition and onset of lactation in cows.
Schams D; Reinhardt V; Karg H
Experientia; 1972 Jun; 28(6):697-9. PubMed ID: 5045177
[No Abstract] [Full Text] [Related]
30. Suppression of mammary hyperplastic nodule formation and pituitary prolactin secretion in mice induced by ergocornine or 2-bromo-a-ergocryptine.
Yanai R; Nagasawa H
J Natl Cancer Inst; 1970 Dec; 45(6):1105-12. PubMed ID: 5530649
[No Abstract] [Full Text] [Related]
31. Ergot drugs suppress plasma prolactin and lactation but not aggression in parturient mice.
Mann M; Michael SD; Svare B
Horm Behav; 1980 Dec; 14(4):319-28. PubMed ID: 6894290
[No Abstract] [Full Text] [Related]
32. Total blockade of phasic pituitary prolactin release in rats: effect on serum LH and progesterone during the estrous cycle and pregnancy.
Döhler KD; Wuttke W
Endocrinology; 1974 Jun; 94(6):1595-600. PubMed ID: 4831125
[No Abstract] [Full Text] [Related]
33. Pituitary prolactin, lactational performance and puerperal infertility.
Robyn C; Meuris S
Semin Perinatol; 1982 Jul; 6(3):254-64. PubMed ID: 6293095
[No Abstract] [Full Text] [Related]
34. Effects of ergocornine and 2-Br-alpha-ergokryptin (CB-154) on the formation of mammary hyperplastic alveolar nodules and the pituitary prolactin levels in mice.
Yanai R; Nagasawa H
Experientia; 1970 Jun; 26(6):649-50. PubMed ID: 5424352
[No Abstract] [Full Text] [Related]
35. Inhibition of lactation in mice following feeding with ergot sclerotia [Claviceps fusiformis (Loveless)] from the bulrush millet [Pennisetum typhoides (Staph and Hubbard)] and an alkaloid component.
Mantle PG
Proc R Soc Lond B Biol Sci; 1968 Jul; 170(1021):423-34. PubMed ID: 4385587
[No Abstract] [Full Text] [Related]
36. Median eminence lesions and serum prolactin: influence of ovariectomy and ergocornine.
Welsch CW; Squiers MD; Cassell E; Chen CL; Meites J
Am J Physiol; 1971 Dec; 221(6):1714-7. PubMed ID: 4941908
[No Abstract] [Full Text] [Related]
37. Galactorrhoea: successful treatment with reduction of plasma prolactin levels by brom-ergocryptine.
Besser GM; Parke L; Edwards CR; Forsyth IA; McNeilly AS
Br Med J; 1972 Sep; 3(5828):669-72. PubMed ID: 4675488
[TBL] [Abstract][Full Text] [Related]
38. Mammotropic effect of prolactin enhanced by thyroidectomy.
Mittra I
Nature; 1974 Apr; 248(448):525-6. PubMed ID: 4824351
[No Abstract] [Full Text] [Related]
39. Difference in mammary gland susceptibility to prolactin between a high and a low mammary tumor strains of mice.
Nagasawa H; Yanai R; Iwahashi H; Fujimoto M; Kuretani K
Endocrinol Jpn; 1967 Dec; 14(4):351-6. PubMed ID: 5631359
[No Abstract] [Full Text] [Related]
40. Comparative effects of hypophysectomy, ergocornine and ergocornine-reserpine treatments on rat mammary carcinoma.
Welsch CW; Iturri G; Meites J
Int J Cancer; 1973 Jul; 12(1):206-12. PubMed ID: 4790704
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
